Active Pharmaceutical Ingredient Sourcing: GMP, APIMF, and Supplier Qualification

What is an active pharmaceutical ingredient?

FDA defines an active ingredient as a component intended to provide pharmacological activity or another direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect body structure or function. The API, or drug substance, is incorporated into the finished drug product with excipients.

The phrase active ingredient is also used loosely in cosmetics and supplements. That marketing usage does not give a botanical extract API status. Before sourcing, document the intended drug product, jurisdiction, pharmacopoeial or in-house standard, dossier route, and whether a drug master file or equivalent package is required.

API manufacturing under ICH Q7

ICH Q7 applies GMP principles across receipt of materials, production of intermediates, isolation and purification, physical processing such as milling, packaging, labeling, quality control, release, storage, and distribution. The degree of GMP control increases as the process moves toward the finished API.

The definition of the API starting material is a critical dossier decision because it establishes where API GMP begins. Buyers should understand the process flow, critical parameters, impurity fate and purge, solvent controls, reprocessing rules, cleaning validation, and data-integrity controls.

• Starting-material justification and supplier controls
• Process description, critical steps, in-process controls, and yield ranges
• Impurity profile, residual solvents, elemental impurities, and microbiology where relevant
• Analytical methods, specifications, stability, retest period, and reference standards
• Packaging, labeling, storage, transport, complaints, recalls, and change control

APIMF and technical documentation

WHO API prequalification evaluates both the API master file and the manufacturing site’s GMP compliance. The APIMF procedure separates information that can be shared with the finished-product applicant from confidential restricted information reviewed by the authority.

A letter of access, current open part, commitments on changes, and alignment between the dossier and the commercial supply chain are essential. A COA alone cannot establish how impurities are controlled, whether the registered process matches the site, or whether changes will be reported.

How to qualify an API manufacturer

Begin with a written user requirement and risk assessment, then conduct document review, sample or method transfer work, quality agreement negotiation, and a site audit proportionate to risk. Confirm inspection history and regulatory status directly with the relevant authority where possible.

Commercial resilience belongs in the qualification file: capacity, batch size, starting-material concentration risk, alternate suppliers, lead time, safety stock, export controls, temperature requirements, and business-continuity plans can affect patient supply as directly as price.

• Legal manufacturer, all processing sites, testing sites, and subcontractors
• GMP evidence, inspection history, deviations, CAPA, and data integrity
• Master-file availability and support for authority questions
• Batch records, COA, method validation or verification, and stability package
• Quality agreement, notification timelines, supply continuity, and recall contacts

Botanical extracts for pharmaceutical development: confirm the boundary

Botanical materials can be used in pharmaceutical research or finished-drug development, but their regulatory pathway, characterization, clinical evidence, and dossier expectations are project-specific. Standardized marker content and GMP-aligned manufacturing do not by themselves establish API approval or WHO prequalification.

Medichem supports botanical projects with specification review, HPLC, UV or TLC method discussions, COA-ready documentation, traceability, and export coordination. A pharmaceutical buyer should separately confirm API status, applicable GMP scope, master-file support, pharmacopoeial requirements, validation package, and authority acceptance before qualification.